Meditoxin® Treatment in Patients With Cervical Dystonia

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 6, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

November 5, 2018

Conditions

DystoniaDystonic Disorder

Interventions

DRUG

Meditoxin

Meditoxin (Botulinum toxin type A)

DRUG

Placebo

Placebo (Normal saline)

Trial Locations (1)

Asan Medical Center, Seoul

All Listed Sponsors

lead

Medy-Tox

INDUSTRY

NCT03232320 - Meditoxin® Treatment in Patients With Cervical Dystonia | Biotech Hunter | Biotech Hunter